Ignite Creation Date:
2024-05-06 @ 2:38 PM
Last Modification Date:
2024-10-26 @ 1:35 PM
Study NCT ID:
NCT04388384
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-10-24
First Post:
2020-05-05
Brief Title:
Real-life Pan-HER-blockade With Neratinib
Sponsor:
Pierre Fabre Pharma GmbH
Organization:
Pierre Fabre Pharma GmbH
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Neoplasm |
Keywords: